A Cross Sectional Study on the Prevalence of Cataract among Patients with Type II Diabetes above 50 Years in a Primary Health Centre in Chennai
DOI:
https://doi.org/10.61986/ijpem.v1.i1.2023.5Keywords:
Prevalence, cataract, Type II diabetesAbstract
Introduction: Cataract is one of the major causes of visual impairment in diabetic patients. This study was done to find out the prevalence of cataract among diabetics above 50 years in a primary health centre in Chennai.
Objectives: To find out the prevalence of cataract among diabetics above 50 years in a primary health centre in Chennai.
Material and methods: This study is a descriptive cross-sectional carried out at Kollumedu Primary Health centre during the time period of June 2022 - September 2022 among 200 diabetic patients who come for treatment. Clinical and demographic details like age, sex, occupation, ocular examination findings, type of cataract, and other clinical details were collected using a detailed questionnaire. The samples were selected by convenient sampling technique. Data was analysed using SPSS version 20 software.
Results: This study revealed that 40% of the participants above the age of 50 years of age had cataract, which is a significant proportion of the diabetic population. About 6% of the participants were newly diagnosed to be having cataract.
Conclusion: Periodic ocular examination has to be recommended for the patients having Type II diabetes.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Dr Advithi, Aravind G, Arun Murugan, Ramasubramanian S, Arulmozhi P, K Sathishkumar (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
International Diabetes Federation. 2015. IDF Diabetes Atlas 7th Edition. Brussels, Belgium. Available from: https://idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html.
Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29. DOI: https://doi.org/10.1186/1478-7954-8-29
Skarbez K, Priestley Y, Hoepf M, Koevary SB. Comprehensive Review of the Effects of Diabetes on Ocular Health. Expert Rev Ophthalmol. 2010;5:557–577. DOI: https://doi.org/10.1586/eop.10.44
Drinkwater JJ, Davis WA, Davis TME. A systematic review of risk factors for cataract in type 2 diabetes. Diabetes Metab Res Rev. 2019;35:e3073. DOI: https://doi.org/10.1002/dmrr.3073
Klein BE, Klein R, Wang Q, Moss SE. Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalmic Epidemiol. 1995;2:49–55. DOI: https://doi.org/10.3109/09286589509071451
Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol. 1998;126:782–790. DOI: https://doi.org/10.1016/S0002-9394(98)00280-3
Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol. 1995;119:295–300.
Saxena S, Mitchell P, Rochtchina E. Five-year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalmic Epidemiol. 2004;11:271–277. DOI: https://doi.org/10.1080/09286580490510733
Kiziltoprak H, Tekin K, Inanc M, Goker YS. Cataract in diabetes mellitus. World J Diabetes. 2019 Mar 15;10(3):140-153. doi: 10.4239/wjd.v10.i3.140. DOI: https://doi.org/10.4239/wjd.v10.i3.140
Kador PF, Wyman M, Oates PJ. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®) Prog Retin Eye Res. 2016;54:1–29. DOI: https://doi.org/10.1016/j.preteyeres.2016.04.006
Pollreisz A, Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:608751. DOI: https://doi.org/10.1155/2010/608751
Snow A, Shieh B, Chang KC, Pal A, Lenhart P, Ammar D, Ruzycki P, Palla S, Reddy GB, Petrash JM. Aldose reductase expression as a risk factor for cataract. Chem Biol Interact. 2015;234:247–253. DOI: https://doi.org/10.1016/j.cbi.2014.12.017
Kinoshita JH. Mechanisms initiating cataract formation. Proctor Lecture. Invest Ophthalmol. 1974;13:713–724.
Oishi N, Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Tanimoto T, Akagi Y. Correlation between adult diabetic cataracts and red blood cell aldose reductase levels. Invest Ophthalmol Vis Sci. 2006;47:2061–2064. DOI: https://doi.org/10.1167/iovs.05-1042
Khan J, Shaw S. Risk of cataract and glaucoma among older persons with diabetes in India: a cross-sectional study based on LASI, Wave-1. Sci Rep. 2023 Jul 24;13(1):11973. doi: 10.1038/s41598-023-38229-z. DOI: https://doi.org/10.1038/s41598-023-38229-z
Klein R, Klein BEK, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984;91:1–9. doi: 10.1016/S0161-6420(84)34337-8. DOI: https://doi.org/10.1016/S0161-6420(84)34337-8
Klein BEK, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin epidemiologic study of diabetic retinopathy. Am. J. Ophthalmol. 1995;119:295–300. doi: 10.1016/S0002-9394(14)71170-5. DOI: https://doi.org/10.1016/S0002-9394(14)71170-5
Raman R, et al. Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, Report No. 17. Investig. Ophthalmol. Vis. Sci. 2010;51:6253–6261. doi: 10.1167/iovs.10-5414. DOI: https://doi.org/10.1167/iovs.10-5414
Craig A, Blumgart E, Tran Y. The impact of stuttering on the quality of life in adults who stutter. J. Fluency Disord. 2009;34:61–71. doi: 10.1016/j.jfludis.2009.05.002. DOI: https://doi.org/10.1016/j.jfludis.2009.05.002
Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J. Diabetes. 2015;6:92–108. doi: 10.4239/wjd.v6.i1.92. DOI: https://doi.org/10.4239/wjd.v6.i1.92
Eye Complications | ADA. Available at https://diabetes.org/diabetes/complications/eye-complications. Accessed on 20 Oct 2023.